Astellas in $3.5bn bid to expand role in US
Health / Medicine Related News
The Japanese pharmaceuticals company has launched a hostile bid for OSI Pharmaceuticals, offering $3.5bn in a deal designed to expand its US presence and activities in oncology
Source: FT.com - Pharmaceuticals